Basic info
Industry
biotechnology research
Sectors
Biotechnology
CRO
process development
specialty chemicals
Agritech
scale-up
peptides
IP consulting
strain bioengineering
Pharmaceutical
natural product chemistry
sustainability
natural products
synthetic biology
Pharma
proteins
Therapeutics
tech transfer
fermentation
microbial strains
biotech
Date founded
2012
Funding rounds raised
I
Isomerase Therapeutics Ltd. raised undisclosed on August 15, 2016
Investors: Abliva AB